CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹1,213 Cr | ₹864 Cr | ₹689 Cr | ₹383 Cr | ₹571 Cr |
What is the latest Capital Work in Progress ratio of CIPLA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹1,213 Cr |
| Mar2024 | ₹864 Cr |
| Mar2023 | ₹689 Cr |
| Mar2022 | ₹383 Cr |
| Mar2021 | ₹571 Cr |
How is Capital Work in Progress of CIPLA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,213 Cr | 40.31 | |
| Mar2024 | ₹864 Cr | 25.41 | |
| Mar2023 | ₹689 Cr | 79.99 | |
| Mar2022 | ₹383 Cr | -32.92 | |
| Mar2021 | ₹571 Cr | - | |
Compare Capital Work in Progress of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹109,683.1 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| MANKIND PHARMA | ₹94,121.6 Cr | 12.5% | 8.5% | -8.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.2% |
2.8% |
-9.1% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses